Alibaba
BABA
Tesla
TSLA
Netflix
NFLX
Apple
AAPL
Intel
INTC
US Stock MarketDetailed Quotes
BOLT Bolt Biotherapeutics
- 0.430
- -0.010-2.27%
Trading Mar 27 14:25 ET
16.49MMarket Cap-0.26P/E (TTM)
0.455High0.430Low130.39KVolume0.450Open0.440Pre Close57.96KTurnover0.47%Turnover RatioLossP/E (Static)38.34MShares1.56052wk High0.29P/B11.82MFloat Cap0.38252wk Low--Dividend TTM27.48MShs Float43.070Historical High--Div YieldTTM5.68%Amplitude0.382Historical Low0.444Avg Price1Lot Size
Bolt Biotherapeutics Key Stats
EPS
According to the latest financial report of Bolt Biotherapeutics, the latest earnings per share (TTM) for the company is -0.42. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Bolt Biotherapeutics's free cash flow? The latest report shows it as -14.43M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Bolt Biotherapeutics shows that the company's current ratio is 3.20, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Bolt Biotherapeutics, the quick ratio is 3.06, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Bolt Biotherapeutics? The latest ROE figure is -24.66%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Bolt Biotherapeutics, the total asset return on investment (ROA) is -15.25%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Bolt Biotherapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Bolt Biotherapeutics, the net profit margin is -1.33K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.